Skip to content
Delayed ~15 min

JNJ Johnson & Johnson

Permanent stock page ↗

Health Care · S&P 500 · Dow Jones

Next earnings: Tue 26 Jan 2027 · before market open

What 31 analyst firms say about Johnson & Johnson: their latest ratings, price targets and how far the stock is from them. How it works

276.22 USD+3.90 (+1.43%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+2.3%to the avg target 282.54 USD+6.32 USD
Buy 17 · Hold 9 · Sell 0

26 rated views · 32 analyst/firm records · 31 firms

Latest report20 Oct 2026avg report date 2 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Dow Jones · Top Picks · 6MBelow the Radar threshold of 8039
  • Dow Jones · Safest consensus · 6MBelow the Radar threshold of 8070
Other indices (1)
  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8044
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8075

Recent analyst activity · last 90 days

Our tracked history has 26 reports on JNJ from 21 analyst firms in the last 90 days (33 firms in the past year).

Comparing each firm's latest target with its previous one: 6 raised their price target, 3 lowered it, 5 left it unchanged and 2 have their first observed target in the past year.

Ratings, latest available report against the previous one: 0 upgrades and 2 downgrades.

Latest observed target change: Wells Fargo raised its target from $275.00 (set 14 Oct 2026) to $287.00 on 16 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusDavid A ToungBuy16 Oct 2026300.00 USD
Bank of America SecuritiesTim AndersonHold29 Sep 2026278.00 USD
BarclaysMatt MiksicHold15 Apr 2026255.00 USD
BernsteinLee HambrightConflictConflicting reports · excluded15 Oct 2026Conflicting reports · excluded
BMO Capital MarketsUnnamed analystBuy11 Dec 2025—
CitigroupJoanne WuenschBuy5 Oct 2026303.00 USD
DaiwaNarumi NakagiriBuy22 Jul 2026260.00 USD
DBSNico ChenHold11 Sep 2026270.00 USD
DZ BankElmar KrausBuy16 Jul 2026290.00 USD
Erste GroupHans EngelHold21 Oct 2026—
Erste Group BankUnnamed analystHold21 Oct 2026—
Evercore ISIUnnamed analyst—20 Oct 2026300.00 USD
Freedom CapitalUnnamed analystBuy16 Jul 2026—
Goldman SachsAsad HaiderBuy16 Jul 2026Conflicting reports · excluded
GuggenheimVamil DivanBuy7 Oct 2026287.00 USD
HSBCMorten HerholdtBuy10 Sep 2026320.00 USD
Johnson RiceIlya ZubkovHold21 Oct 2026—
JPMorganChris SchottHold29 Sep 2026285.00 USD
Leerink PartnersDavid RisingerBuy14 Oct 2026272.00 USD
Morgan StanleyTerence FlynnBuy15 Oct 2026292.00 USD
Raymond JamesJayson Bedford—3 Aug 2026280.00 USD
RBC Capital MarketsTrung HuynhBuy14 Oct 2026280.00 USD
RedburnSteven K ChesneyHold14 Sep 2026220.00 USD
ScotiabankLouise ChenBuy22 Sep 2026305.00 USD
StifelRick Wise—15 Jul 2026260.00 USD
TD CowenJoshua T JenningsBuy20 Oct 2026300.00 USD
TD CowenMichael NedelcovychBuy20 Oct 2026300.00 USD · 13 Jul 2026
UBSMichael Yee—14 Oct 2026270.00 USD
Weiss RatingsUnnamed analyst—23 Oct 2026—
Wells FargoLarry BiegelsenBuy16 Oct 2026287.00 USD
Wolfe ResearchAlexandria HammondBuy16 Jul 2026300.00 USD
Data feed RESEARCHResearch TeamHold29 Apr 2026267.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 03:57 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.